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FULL ARTICLE
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The ability to resolve multiple fluorescent emissions
from different biological targets in video rate applica-
tions, such as endoscopy and intraoperative imaging, has
traditionally been limited by the use of filter-based
imaging systems. Hyperspectral imaging (HSI) facili-
tates the detection of both spatial and spectral in-
formation in a single data acquisition, however, in-
strumentation for HSI is typically complex, bulky and
expensive. We sought to overcome these limitations us-
ing a novel robust and low cost HSI camera based on a
spectrally resolved detector array (SRDA). We in-
tegrated this HSI camera into a wide-field reflectance-
based imaging system operating in the near-infrared
range to assess the suitability for in vivo imaging of
exogenous fluorescent contrast agents. Using this fluo-
rescence HSI (fHSI) system, we were able to accurately
resolve the presence and concentration of at least 7 flu-
orescent dyes in solution. We also demonstrate high
spectral unmixing precision, signal linearity with dye
concentration and at depth in tissue mimicking phan-
toms, and delineate 4 fluorescent dyes in vivo. Our ap-
proach, including statistical background removal, could
be directly generalised to broader spectral ranges, for
example, to resolve tissue reflectance or auto-
fluorescence and in future be tailored to video rate ap-
plications requiring snapshot HSI data acquisition.
* Corresponding author: e-mail: seb53@cam.ac.uk
Supporting information for this article is available on the WWW under https://doi.org/10.1002/jbio.201600304
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1. Introduction
HyperSpectral Imaging (HSI) is a powerful ana-
lytical tool based on the detection of both spatial
and spectral information within a single data set, re-
ferred to as a HSI cube (x-y-l). Originally conceived
for remote sensing [1], HSI has impacted fields as
diverse as food inspection [2] and forensics [3]. The
power of HSI lies in the ability to determine the
chemical composition of a sample based on
characteristic spectral signatures, using multivariate
statistical methods to produce a spatial map of the
chemical constituents.
The ability to detect multiple fluorescent labels
targeted to different processes is highly advanta-
geous across a range of length scales in biomedical
imaging: from studying complex molecular inter-
actions in cells at super-resolution [4]; through mon-
itoring contrast agent biodistribution in small ani-
mals [5,6]; to diagnosing, characterising and
resecting cancer in humans [7,8]. Biomedical appli-
cation of HSI has already enabled numerous fluo-
rescent contrast sources (e.g. small molecule dyes,
fluorescent proteins, autofluorescence) to be de-
lineated within a single data set. Implementations of
fluorescence HSI (fHSI) systems in microscopic [9]
and small animal imaging [10,11] based on tunable
spectral filters have gained commercial traction
[12, 13], however, in practice these systems are typi-
cally used to resolve fewer than 3 fluorescent dyes
or proteins [9,14–17]. Increasing the number of re-
solvable labels to >5 has required the use of nar-
rowband emitters such as quantum dots [18] or spe-
cialized sample geometry [19].
To date, translating the power of fHSI into appli-
cations in humans, such as endoscopic and intra-op-
Figure 1 Characterization of the hyperspectral imaging (HSI) camera. (A) The HSI camera contains a CMOS sensor with
row-wise deposition of Fabry-Pérot etalon cavities (simplified schematic); each ‘spectral band’ occupies 8 pixel rows. (B)
Experimental setup for calibration. (C) The calibration procedure located 72 spectral bands with peak wavelength be-
tween 600 and 900 nm; here shown for a camera objective F/# of 1.65. (D) The quantum efficiency as a function of wave-
length – QE(l) – for each of the 72 spectral bands. As the F/# of the coupled camera objective increases, the total signal
falling on the sensor decreases (E), whilst the full width at half maximum (FWHM) narrows (F) differing notably from the
QE(l) collimated light (F, dashed line). Data in (E) and (F) are taken from spectral band 32.
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erative imaging, has been challenging due to the
need for complex, bulky and expensive in-
strumentation with limited frame rate. Nonetheless,
the ability to characterize both endogenous tissue
contrast based on diffuse reflectance and to identify
the presence and concentration of exogenous small
molecule fluorescent dyes [17, 20] is highly desirable
in the clinic.
Spectrally resolved detector arrays (SRDAs) –
where the spectral filters are deposited on a glass
substrate either in front of [21,22], or directly on top
of, the sensor array [23,24] – are promising for fu-
ture clinical application of fHSI. SRDAs are ex-
tremely compact and robust and therefore well suit-
ed for use in an endoscopy suite or operating
theatre. They also have the potential to be produced
at very low cost, as the filters may be deposited on
the sensor array during the lithography process [23].
When the spectral filters are deposited on the sensor
in a pixel-wise mosaic pattern, video rate spectral
imaging is possible [24]. Encouragingly, early appli-
cations of snapshot SRDA have shown promise in
neurosurgery [25] and ophthalmology [26] using
white-light reflectance imaging.
Here, we evaluated the performance of an
SRDA-based HSI camera for fluorescence imaging,
with a view to future clinical application. While the
SRDA filters can be deposited pixel-wise for real-
time ‘snapshot’ imaging [24–26], we used row-wise
filters to perform ‘pushbroom’ HSI in order to main-
tain high spatial and spectral resolution in this initial
technology evaluation. The utility of the ‘pushb-
room’ SRDA used in this study has been explored in
a wide range of applications, from food inspection to
agricultural monitoring [27]. Following detailed
characterization of the HSI camera, we created a re-
flectance-based wide-field imaging system in order
to provide a first proof-of-concept for fHSI using an
SRDA. We evaluated: HSI response linearity; spec-
tral unmixing precision; and delineation of re-
flectance and fluorescence light in tissue. The wide-
field fHSI system based on our SRDA can resolve at
least 7 fluorescent dyes in solution and at least 4 in
small animals, showing promising performance for
future clinical application.
2. Methods
2.1 Hyperspectral imaging camera and
calibration
The HSI camera SRDA (Imec) monolithically in-
tegrates a set of 100 Fabry-Pe´rot etalon filters be-
tween 600 and 1000 nm (Figure 1A) on a CMOS
sensor (CMV2000; CMOSIS) packaged within a
camera system (Q-2 A340 m/CL; Adimec). The Fab-
ry-Pe´rot etalon filters are row-wise deposited on the
sensor to form spectral bands; each spectral band
occupies 8 pixel rows. Transmission efficiencies of
up to 73 % have been reported for the filters in this
HSI camera SRDA [23]. For all measurements, in-
tegration time was set to be 99.73 ms, frame period
to 100 ms, gain to 1 and 2 tap acquisition of 10 bit
images (without image averaging) in linear mode
(dynamic range of 60 dB) was used. Spatial calibra-
tion of filter row position was achieved by identify-
ing the pixel rows that responded similarly to diffuse
light at each wavelength based on a city block met-
ric analysis [28]. We measured photon transfer
curves [29] with the HSI camera by illuminating the
sensor directly using two broadband LED arrays
(Aspect Systems) with peak emission wavelengths of
635 nm and 850 nm respectively. The conversation
gain was found to be 0.160.01 e-/DN and the read-
out noise was found to be 950.07 DN (mean 
standard error across spectral bands). HSI camera
quantum efficiency (including optical filter trans-
mission and sensor response) as a function of illumi-
nation wavelength was measured using a commer-
cial calibration system (Aspect Systems) according
to standard methods [29,30] with collimated light
produced using a bi-convex lens (LB1723-B; Thor-
labs). Quantum efficiency (QE) was defined as
(1)
where DN(l) is the digital number of the averaged,
dark subtracted pixels within the spectral bands, Ke
is the conversion gain of the sensor, Ipeak the peak
photon intensity measured with the calibrated pho-
todetector, t the integration time and Apixel the pixel
area [30]. Imaging was performed using an objective
lens (35 mm VIS-NIR Compact Fixed Focal Length
Lens, Edmund Optics) and 600 nm IR long pass fil-
ter (Imec). To assess the impact of illumination an-
gle (F/#), we used a custom monochromator-in-
tegrating sphere system (Figure 1B). A broadband
halogen light source (OSL2 with OSL2B2 bulb;
Thorlabs) was coupled via a 0.48 NA 1000 mm diam-
eter fiber (M71 L01; Thorlabs) into a mono-
chromator (CM110 1/8 m; Spectral Products). The
monochromatic light was then relayed via an optical
fiber (M71 L01; Thorlabs) to an integrating sphere
(AS-02994-033; Labsphere). Isotropically diffuse
light output from the integrating sphere was directly
input to the camera objective at the 1.5” sphere out-
put port. The focal length of the objective was kept
at infinity throughout the measurements to avoid fo-
cusing on the internal structure of the integrating
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sphere. The monochromator was scanned between
580 and 920 nm in 3 nm increments and intensity
spectra were acquired via a calibrated inspection
spectrometer (AvaSpecULS2048-USB2-FCDC;
Avantes). We defined the ‘relative spectral response’
recorded with the objective lens in place as
(2)
where SR is the baseline corrected relative spectral
response of the camera in DNmW1nm1, DN is the
digital number output of the camera, l the peak
wavelength output from the monochromator and
Ipeak is the peak intensity recorded by the inspection
spectrometer in mWcm2.
2.2 Wide field fHSI system design
The HSI camera was mounted onto a strong alumi-
nium frame (XT95-500, XT95P3, XT95P12/M and
XT95P11/M; Thorlabs) above the sample using a
custom adapter, designed to minimize mechanical
vibrations. The system was enclosed in a light tight
box. Sample translation for line scan imaging was
achieved using a motorized translation stage
(LTS150; Thorlabs), which was synchronized to the
process of image acquisition. The sample was con-
secutively translated a distance equivalent to that of
one spectral band before each image acquisition.
Our alignment procedure has been detailed else-
where [28]. Briefly, alignment was achieved by ac-
quiring an HSI cube from a printed grid, placed on
top of a reflectance target (Lambertian White
Screen, SG3151-0; Sphere Optics) in the sample
plane and illuminated with a halogen lamp. Fine
tuning of sample positioning orthogonal to the scan-
ning was achieved using manual stages (L200/M,
PT1/M; Thorlabs). The height of the sample stage
and the focus of the objective were adjusted such
that the field-of-view (FOV) was 70 mm320 mm;
the smallest FOV was used to maximize the de-
tected fluorescence signal. For an objective F/# of
1.65, the spatial resolution at this FOV was de-
termined to be 0.56 lines/mm using a USAF test
chart (R1DS1N; Thorlabs). No noticeable keystone
or spectral smile aberrations were observed in the
image data (see Supporting Figures S1 and S2).
Sample illumination was provided by a custom
LED ring of 50 mm internal radius. Three colors of
high power LEDs with peak wavelengths 590, 660, and
732 nm (LZ1-10 A100, LZ1-10R200, LZ1-10R30;
MCPCB mounted from LED Engine) were mounted
on a copper ring, each LED controlled via a separate
current controller (LEDD1B; Thorlabs) with negli-
gible intensity drift (<2 %). Six LEDs of each type
were connected in series equidistant around the in-
ternal rim of the ring and photographic diffuser paper
(Lee White Diffusion 129; Calumet Photographic) was
placed underneath. We compared data acquired with
and without crossed linear polarisers (LPVISE2X2;
Thorlabs) to compare hardware specular reflection re-
moval with our background removal methods im-
plemented in software.
The power density at the sample was calibrated
using an optical power meter (1916-R; Newport)
centrally placed in the sample area. Spatial illumina-
tion uniformity was mapped separately for each
LED color at 100 mW/cm2, with and without the
crossed linear polarisers, by translating an optical
power meter in 0.5 cm steps in x and y across the
sample area. The spatial non-uniformity did not ex-
ceed 5 % for the LEDs without crossed polarisers.
The addition of crossed polarisers (and removal of
the diffusion paper) substantially affected the uni-
formity of the illumination increasing to 29 % at
660 nm due to a combination of the removal of the
diffusion paper and the low quality of the polarizing
filters.
2.3 Data Analysis
For every experiment, a dark and ‘flat’ HSI cube were
acquired respectively by turning off all LEDs or by
illuminating the sample prior to addition of the fluo-
rescent dyes. Raw data is available by contacting the
corresponding author of the manuscript. Initial pre-
processing steps (see Supporting Methods for more
details) include: dark subtraction, to account for any
sensor non-uniformities; edge correction, to account
for a slight mismatch with the filter edges and pixel
positions (Supporting Figure S3); and spatial vignet-
ting correction, using an HSI cube acquired under
broadband illumination in the sample plane to provide
a vignetting correction mask for each spectral band.
Finally, background removal is performed to address
the presence of specular reflections in our data, which
comprise 1–5 % of the image pixels in well plate and
tissue phantom data. Strong specular reflections in the
well plates arise due to meniscus effects in the droplets
containing fluorescent dyes, and moist or wet areas in
the tissue phantoms. For mouse skin, which is more
diffusely reflective, less than 0.003 % of image pixels
are affected. A ratiometric thresholding method was
developed to remove areas of strong specular re-
flection from our quantitative analysis (see Supporting
Methods).
We tested two software background removal meth-
ods, which exploit the spectral dimension of the in-
formation collected in the HSI cube, and compared
J. Biophotonics 10 (2017) 843
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the result to the inclusion of crossed linear polarisers
in the hardware, which remove only surface specular
reflections. The advantage of performing background
removal in software, assuming we are able to achieve
a comparable performance for reflectance removal as
in hardware, is the potential to extract information
from the diffuse reflectance light in a clinical scenario.
The ‘brute force’ software approach mimics the action
of applying optical band-pass filters to block the re-
flectance light. The maximum signal intensity of the
reflected LED illumination for the power levels chos-
en in this study was first determined by imaging the
uniform reflectance target under our standard illumi-
nation conditions. For spectral bands 9–17 and 21–35,
which would be adversely affected by reflectance of
the LED illumination, bands where the signal intensity
exceeded 10 % of the measured maximum reflectance
intensity were then rejected from the analysis. The
spectral bands rejected were kept fixed throughout the
study. Orthogonal subspace projection (OSP) [34] uses
the ‘flat’ HSI cube to obtain the principal components
of the background. A matrix of orthogonal basis spec-
tra V was taken from the background HSI cube (5
most significant principal components). The projec-
tions of V on the original endmembers (a) were then
subtracted to produce background removed endmem-
bers (r, input to spectral unmixing as described below)
according to r=a aV T V . This approach has the ad-
vantage of removing not only specular reflections but
also any other sources of stray background light.
‘Endmembers’ are the spectra to be fitted using
spectral unmixing. To account for system-dependent
variations in the recorded spectral profiles, we used
the spectra of the fluorescent dyes recorded by the
wide field fHSI system in a single reference meas-
urement [14, 16] of the fluorescent dyes at 40 mM
concentration in a well plate. Endmembers were ex-
tracted as average spectra from manually placed
ROIs (20 pixels radius) positioned at the known po-
sition of the dye in the pre-processed ‘reference’
HSI cube. The background endmember was ob-
tained by averaging the pixel spectra from the pre-
processed ‘flat’ HSI cubes. Separate dye dilutions
were prepared for the acquisition of each ‘reference’
HSI cube, meaning that endmembers were always
collected from a separate sample than that being
classified. Classification was achieved by non-neg-
ativity constrained least squares (NNLS) spectral
unmixing using the Matlab function lsqnonneg. The
result of the spectral unmixing procedure is an
abundance map for each of the fluorescent dyes and
one for the background. ROIs were placed over the
abundance maps; for the well plate data a ratio-
metric thresholding method was used to avoid areas
of strong specular reflections (see Supplementary
Informations for further details).
2.4 fHSI imaging of multiple fluorescent
dyes in well plates and phantoms
A 40 mM dilution of each of AF610, AF647, AF700
and AF750 (A30050, A20006, A20110 and A37568,
all NHS ester; Invitrogen) was prepared in phos-
phate buffered saline (PBS) (10010015; Thermo
Fisher). A well plate (18 well, m-slide, 81826; ibidi)
containing 30 mL of each dye in a separate well,
along with a PBS control was used to acquire the
‘reference’ HSI cube (with and without crossed po-
larizers), from which endmembers could be ex-
tracted. A ‘flat’ HSI cube of a well plate containing
only PBS was recorded for OSP background re-
moval. Plates containing both dilution series of each
dye (1:2 steps from 10 mM to 625 nM) and mixtures
of different dyes were then imaged for performance
evaluation. Two duplicates of each concentration
and two PBS blanks were pipetted in opposite direc-
tions along two rows of the well plate, to ensure re-
peatability within the FOV. Absorption and fluores-
cence spectra, as well as the accuracy of the
dilutions, were verified using microplate readers
(FLUOstar and CLARIOstar; BMG LABTECH).
A further well plate was imaged containing 40 mM
dilutions of three additional fluorescent dyes to the
Alexa Fluors: Cyanine 7.0; Sulfo-Cyanine 7.0; and
Cyanine 7.5 (Cy7, SCy7 and Cy7.5, 25090, 25390,
26090; Lumiprobe). 20 mL of 40 mM dye dilutions
prepared in ethanol –to avoid aggregation of the cy-
anine dyes – were imaged.
For phantom experiments, 1.5 % agar solution
(05039-500G; Fluka) was mixed with intralipid
emulsion (20 % emulsion, I141-100ML; Sigma-Al-
drich) to provide a scattering coefficient of 5 cm1 at
633 nm. A 0.75 % volume of 0.5 mgml1 nigrosin
(198285-25G; Sigma-Aldrich) was then added to
provide an absorption coefficient of 0.05 cm1 at
633 nm. While liquid, the phantom base material
was poured into multiple petri dishes (664160;
Greiner Bio-One) to depths of either 0.2 or 1 cm.
Fluorescent target inclusions were made using trans-
parent plastic straws with an internal diameter of
0.3 cm (391SIPCL; Plastico). The transparent straws
were cut into 1 cm long pieces and one end of each
piece sealed with a glue gun (PA6-GF30: Type PXP
06; Henkel Pattex Supermatic). Eight 1 cm long
straw pieces were inserted into a 1 cm thick phan-
tom slab, with the glue sealed end directed towards
the bottom of the petri dish; half of the straw in-
clusions were filled (50 mL) with a 40 mM solution of
each of the fluorescent dyes (AF610, AF647, AF700
and AF750) in equal part phantom base material
and PBS and half were filled with PBS and phantom
base material. A second equivalent phantom was
prepared with all the straw inclusions filled with the
844 A. S. Luthman et al.: Fluorescence hyperspectral imaging (fHSI) using a spectrally resolved detector array
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PBS and phantom base material mixture for the
‘flat’ HSI cube acquisition.
2.5 In vivo imaging
All animal procedures were conducted under a proj-
ect license issued under the United Kingdom Ani-
mals (Scientific Procedures) Act, 1986 (70-8214).
The project license was reviewed by the local Ani-
mal Welfare and Ethical Review Board and the spe-
cific experimental protocol was approved locally by
the Named Animal Care and Welfare Officer at the
Cancer Research UK Cambridge Institute under
compliance form number CFSB0964 and conducted
by individuals holding personal licenses. 40 mM dilu-
tions of each of the AlexaFluor dyes and an equal
parts mixture of all four (from 30 mM dilutions)
were prepared in a 1:1 solution of PBS and phenol-
red-free matrigel (356231; Corning). Experiments
were performed in nude mice (n=2) maintained un-
der inhaled anaesthesia using isoflurane mixed with
100 % oxygen for a maximum of 2 hours for the en-
tire study. During imaging on the fHSI system, the
mouse was placed on a heat pad (Physiosuite Mon-
itoring Module, Kent Scientific Co.) within a be-
spoke 3-D printed animal holder. 30 mL of each dye
preparation was injected subcutaneously using a
Hamilton syringe into the flank of the mouse. The
contralateral side of the mouse was used as an imag-
ing control for acquisition of the ‘flat’ HSI cube. Im-
ages were also acquired using an IVIS200 (Perkin
Elmer) per standard operating procedures to verify
successful injection and placement of the fluorescent
dyes using a filter-based fluorescence imaging sys-
tem.
3. Results
3.1 Calibration of the HSI camera
We first established the performance capabilities of
our HSI camera. We selected a near-infrared camera
to be compatible with in vivo imaging of exogenous
fluorescent dyes. The monolithically integrated spec-
tral filters are formed from Fabry-Pe´rot etalon cav-
ities deposited over 8 pixel rows on the sensor (re-
ferred to as a ‘spectral band’, Figure 1A). The cavity
size defines the center wavelength of the filter. The
reflectivity of the cavity mirrors and the angle of in-
cidence of the illumination light determine the full
width at half maximum (FWHM) of the spectral re-
sponse [31]. To fully understand this behaviour, we
used a monochromator-integrating sphere system
(Figure 1B) to characterize the response of the 72
spectral bands in the wavelength range of interest
for this study (600 – 900 nm, Figure 1C). The peak
QE of the spectral bands was found to vary between
1.5 % to 15.9 % when using collimated light (Fig-
ure 1D). The mean intraband standard deviation of
the peak wavelength and FWHM of the spectral re-
sponse of 8 pixel rows composing a spectral bands
were 2.00 nm and 0.37 nm respectively. In agree-
ment with theory [31, 32], the spectral response is
highly dependent on the F/# of the objective lens
used for imaging (Figure 1E, F), with a lower optical
throughput and narrower FWHM for increasing F/#.
As the F/# of the objective lens is changed from 1.65
to 4.0, the optical throughput (area-under-curve) de-
creases by 841 %, while the FWHM decreases by
82 % (mean  standard deviation across all spec-
tral bands). The full spectral data is shown in Sup-
porting Information Figure S4. The center wave-
length also converges on the value measured using
collimated light during the QE calibration. For fluo-
rescence imaging, with low light levels and broad
spectral profiles, we selected a low F/# to maximize
optical throughput (set to 1.65 for the remainder of
this work).
3.2 Design and characterization of the
fluorescence HSI wide-field system
To provide an initial proof-of-concept for fHSI rele-
vant to clinical applications, we decided to create a
simple reflectance-based demonstrator system,
which mimics typical sample and illumination geom-
etry. This allowed us to specifically capture and ex-
plore the hardware and software challenges of per-
forming fHSI without adding all of the complexities
that would be associated with a fully functional en-
doscopic or intraoperative system. We mounted the
HSI camera above a motorized translation stage
(Figure 2A). The sample is scanned under the HSI
camera, with a single image acquired by the HSI
camera at each scan position. Each image from the
HSI camera has dimensions of x  l, while the line
scan adds the y dimension. The HSI ‘data cube’ is
reconstructed offline (procedure outlined in Fig-
ure 2B) after the spectral scan by stitching together
the spectral data from each y step to produce an x
y l matrix (20483576372=84.9 MegaPixels; x-y
pixel dimension 34.2 mm in the FOV). Line scanning
requires an acquisition time of up 4 minutes per HSI
cube, but allows us to maximize the spectral and
spatial information available in our SRDA. While
acceptable in the present system, we would need to
trade off spectral and spatial resolution to transition
into a pixelwise filter deposition for future clinical
implementations.
J. Biophotonics 10 (2017) 845
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HSI traditionally uses either broadband white
light or narrowband filters for illumination [20]. We
took an intermediate approach, using an light emit-
ting diode (LED) ring composed of 3 LED colors:
one outside of the spectral response range of the
HSI camera at 590 nm, and two within the range at
660 nm and 732 nm (Figure 2C). LEDs were chosen
to allow flexible ‘plug and play’ exchange of ex-
citation wavelengths. We set the power density of
each color to 100 mWcm2 in the sample plane for all
experiments. Light from all LEDs simultaneously il-
luminated the full FOV throughout the data acquis-
ition.
3.3 fHSI of multiple fluorescent dyes in well
plates
Having implemented and calibrated the system hard-
ware, we then sought to evaluate the imaging perform-
ance in a well-controlled sample. Four fluorescent dyes
initially used to assess fHSI performance were Alexa-
Fluor (AF) 610, 647, 700 and 750. The dyes were chos-
en to have a relatively high spectral peak separation (~
50 nm) and a range of quantum yields, with variable
overlap between their fluorescence emissions and the
reflectance of the LED excitation light (AF647 and
AF700: strongly overlapping; AF610: moderately over-
lapping; AF750: separated; Figure 2C). We used a sim-
ple well plate with 30 mL microwells containing first
each pure fluorescent dye in a 1:2 dilution series start-
ing from a concentration of 10 mM then mixtures of
the four dyes at a final concentration of 10 mM. A
‘flat’ HSI cube was acquired from a reference well
plate without fluorescent dyes; an ‘endmember’ HSI
cube was acquired from another plate containing only
pure fluorescent dye solutions at 40 mM (Figure 2)
[14, 16].
3.3.1 fHSI data analysis
To extract the fluorescent dye composition at a
given spatial location within the fHSI data cube,
the data was processed as illustrated Figure 2B. A
key aspect of the pre-processing is background re-
Figure 2 Overview of the fluorescence HSI (fHSI) wide field system. (A) The sample is scanned under the HSI camera.
(B) The HSI cube is reconstructed offline by stitching together the spectral band data from each scan position. The raw
HSI cube then undergoes several pre-processing steps – including background removal prior to spectral unmixing and
quantitative analysis. (C) Emission spectra of the 3 LED colors (shaded grey) overlapped with the excitation (shaded
curves) and emission (line) spectra of the fluorescent dyes. Raw spectra recorded by the fHSI system for pure dye sol-
utions (D) are used to extract endmembers, shown after background removal via orthogonal subspace projection (E).
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moval. When performing fluorescence imaging in
reflectance mode, the excitation light is normally
removed by band exclusion filters or by changing
the light path using dichroic mirrors. For clinical
applications, however, diffuse reflectance signals
in the near-infrared can give additional in-
formation related to blood oxygenation. We there-
fore exploited the spectral resolution of the HSI
system to perform software background removal
from the fluorescence data, such that for future in
vivo applications the reflectance signal could also
be used. We compared two methods: ‘brute force’
and orthogonal subspace projection (OSP). The
conventional filter-based reflectance removal was
mimicked mathematically in software by ‘brute
force’ exclusion of the spectral bands encompass-
ing the peaks of the LED excitation. Orthogonal
subspace projection (OSP) removes the principal
components (PCs) of the ‘flat’ HSI cube (acquired
before fluorescent dye administration) from the
fHSI data cube to produce new endmembers
[33, 34] (Figure 2E). OSP is a well established
method of spectral background characterization in
hyperspectral chemometrics [33]. These software
methods were compared to the introduction of
crossed polarisers in hardware, which will remove
the contribution of surface reflections, and the
case without any reflectance removal.
The pre-processed HSI cube was analysed using
non-negativity constrained least squares (NNLS)
spectral unmixing based on data extracted from the
‘endmember’ HSI cubes (Figure 2B). The final out-
put is an abundance map for each fluorescent dye
and one for the background, where the intensity
scale is the least squares (LS) score. Region of inter-
est (ROI) data is extracted from these images for
analysis.
3.3.2 fHSI spectral unmixing performance
We evaluated the impact of different background re-
moval methods used in data pre-processing on data
quantification. ROIs of 65 pixels radius were man-
ually placed over the wells in the well plate image to
extract an average LS score over each well. Fig-
ure 3A shows the LS score recorded for the four flu-
orescent dyes at 10 mM; endmembers at 40 mM con-
centration were input to the NNLS so a LS score of
0.25 would be expected at 10 mM, with 0 for the
background. In all cases, applying NNLS without
background removal results in an incorrect LS score
assignment to both the signal and background, with
the exception of the signal from AF750 for which
the fluorescence signal is well separated from the re-
flectance light. AF647 and AF700 show poorest per-
formance without background removal, as expected
based on the strong overlap of their emissions with
the reflectance light. All background removal meth-
ods improve this to some extent, however, brute
force and hardware cross polarisers removal both in-
crease mis-fitting to the background. The statistical
method of OSP provided the optimal combination
of accuracy in the signal and background, although
consistently underestimates the LS score expected
for the signal. In all cases, the AF610 dye is least
well resolved, most likely due to the low detection
sensitivity of the HSI camera in this spectral region
(Figure 1D). Nonetheless, a quantitative response is
observed based on the high R2 values for all linear
fits to the LS scores of the whole dilution series
across the range of dyes (AF610: y=0.0065x+0.027,
R2=0.69; AF647: y=0.021x0.012, R2=0.95;
AF700: y=0.018x+0.02, R2=0.94; AF750: y=
0.019x0.01, R2=0.98).
In addition to the LS score, we defined the
spectral unmixing precision (SUP): the ratio of the
LS score for the correct abundance map to the
sum of scores recorded from the same spatial loca-
tion across all other fluorescent dye abundance
maps. For each background removal method, the
spectral unmixing precision is compared to the
ground truth (Figure 3B). Again, the OSP method
performs well across the board, qualitatively al-
lowing a majority decision to be made regarding
the dye or dye(s) present in a given location in the
well plate. The F/# of the objective did not have
any significant impact on these results (Supporting
Information Figure S5). The results from 2 and 4
component mixtures are illustrated in Figure 3C
compared to the ground truth. The fundamental
limitation of fluorescent dye mixtures with broad
overlapping emissions (not limited to our applica-
tion) is ‘bleed over’. This refers to the fact that the
emission of one fluorescent dye can immediately
excite another in the same solution. For example,
the area of overlap between the AF610 emission
spectrum and the excitation spectra of the other
dyes used may be up to 65 %, 48 % and 28 % for
AF647, AF700 and AF750 respectively. Thus,
while the primary constituents in each well can be
identified in most cases, extraction of quantitative
concentration data will be difficult. AF610 is con-
sistently underestimated in mixtures, likely due to
a combination of low camera sensitivity as noted
above but also the overlap between AF610’s emis-
sion spectra and the reflectance light.
To assess the response of the system in the case
of more overlapping spectra, we introduced a well
plate containing 3 additional fluorescent dyes (Cy7,
SCy7 and Cy7.5) with significant spectral overlap
with both the reflectance light and the existing
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AlexaFluor dyes. The abundance maps for each flu-
orescent dye is shown in Figure 4A. Based on meas-
ured endmembers (Figure 4B), all 7 dyes can be
clearly resolved (Figure 4C). A limited degree of
misfitting between AF750, Cy7, SCy7 and Cy7.5
was observed, which would be expected based on
the similarity of their emission spectra.
To quantify the repeatability of the fHSI data, a
well plate containing 4 wells of 30 mL of 40 mM dilu-
tions of AF647 and 750 was imaged 8 consecutive
times over a 35 minute time period. The coefficient
of variation of the unmixed fluorescence signal (re-
flectance removal via OSP) with time was found not
to exceed 6% for any of the wells. Based on the low
coefficient of variation, we can conclude that photo-
bleaching of the dyes does not occur at the illumina-
tion levels and acquisition times used in this study.
Well plates containing 30 mL of 40 mM dilutions of
AF610, AF647, AF700 and AF750 were also imaged
on four separate occasions over a 6 month period;
the average coefficient of variation of the unmixed
fluorescence signal from the dyes over the different
imaging sessions was 16 %. The larger variations in
the fluorescence signals is likely due to the different
positioning of the well plate within the camera FOV
between imaging sessions.
Figure 3 fHSI accurately identifies each fluorescent dye and is able to perform multiplexing. (A) Non-negativity con-
strained least squares (NNLS) spectral unmixing was applied to well plates containing pure and mixed solutions of the
different fluorescent dyes at 10 mM concentration, with and without background removal. The least squares (LS) scores
from the dye abundance map within the expected well (black striped bars) and in a background well containing phosphate
buffered saline (PBS) only (red bars) are compared. The error bars indicate the range over two dye and PBS wells in the
same well plate. (B) Spectral unmixing precision (SUP) is the ratio of the LS score for the correct abundance map to the
sum of scores recorded from the same well across all other fluorescent dye abundance maps (but not the background
abundance map). For example, in the case of a well containing AF610, the LS scores are used to calculate the SUP as
follows: SUP=AF610 / (AF610+AF647+AF700+AF750). The ground truth for each pure dye dilutions gives SUP=1.
(C) Multiplexing capability is demonstrated using pie charts to show the SUP for pure dyes (average over two wells of 10
mM from dilution series) as well as 2 and 4 component mixtures.
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3.4 fHSI of multiple fluorescent dyes in
tissue mimicking phantoms
We next used tissue mimicking agarose phantoms to
explore the spectral unmixing performance and
depth sensitivity in a more realistic background. The
original four AlexaFluor fluorescent dyes were in-
dividually placed in an intralipid phantom at a con-
centration of 40 mM, confined in the phantom using
transparent plastic straws. Initially the phantom was
imaged with the top of the straw exposed, then agar-
ose gel slabs of up to 2.5 mm thickness were sequen-
tially placed on top to gradually increase the depth
(Figure 5A, B). Regions of interest of 50 pixel radius
were manually placed over the inclusions or back-
ground regions to extract an average least squares
(LS) score over each well. The weighted contrast to
noise ratio (CNR) [35] was calculated taking the sig-
nal as the LS score correctly assigned to the fluo-
rescent dye inclusion and the background as the LS
score incorrectly assigned to the background region
in the same fluorescence abundance map. CNR re-
Figure 4 Up to 7 fluorescent contrast agents can be resolved in solution. 40 mM concentrations of AF610, 647, 700, 750,
Cy7, SCy7 and Cy7.5 in ethanol were imaged on the same well plate and processed using OSP to produce abundance
maps (A). The resulting endmembers (B) were used to identify the spectral unmixing precision (C), with only a limited
degree of misfitting between AF750, Cy7, SCy7 and Cy7.5, which would be expected based on the similarity of their
emission spectra.
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mained above 4 to depths of: AF610, 2.5 mm;
AF647, 2.5 mm; AF700 4.0 mm and AF750, 2.5 mm
(indicated in red in Figure 5C), while linearity per-
sisted for up to a further 4 mm, with high R2 values
of the linear fits. Spectral unmixing precision was
also evaluated (Figure 5D), giving similar perform-
ance as in well plates. Full quantification data for LS
score and SUP are shown in Supporting Information
Figure S6.
3.5 fHSI of multiple fluorescent dyes in vivo
To assess the in vivo imaging performance of wide-
field fHSI, we administered subcutaneous injections
of the four AlexaFluor fluorescent dyes (40 mM in a
1:1 solution of PBS and phenol red-free matrigel) in
the flank of a nude mouse maintained under anes-
thesia. Prior to imaging on the fHSI system, the suc-
cessful injection and placement of the fluorescent
dyes was verified on a filter based optical imaging
instrument (IVIS200, Figure 6A, B). The locations
of all four fluorescent dyes could be retrieved from
their respective fHSI abundance maps (Figure 6A).
In mixtures (Figure 6B), only three dyes can be ob-
served clearly in the abundance maps, due to the
challenges noted above with detection of AF610 in
mixtures. The successful detection of the dyes on the
fHSI system is reinforced by LS scores and SUP ex-
tracted from 30 pixel radii ROIs placed over the in-
jection site of the separate subcutaneous dye in-
jections (Figure 6C, D). As would be expected, the
equivalent quantification from the filter-based opti-
cal imaging instrument shows significant overlap be-
tween the recorded fluorescent dye emissions (Fig-
ure 6E), highlighting the previously established
value of using fHSI approaches for in vivo imaging
[10].
4. Discussion
Hyperspectral imaging (HSI) records both spatial
and spectral information in a single data set. We hy-
pothesized that the use of SRDAs could provide a
compact and cost effective approach to acquisition
of fHSI data, which would aid future clinical appli-
cation of the approach. We first performed a techni-
cal characterization of the novel SRDA-based HSI
camera. Our HSI camera calibration explored the
impact of illumination angle of incidence on the
spectral response of the monolithically integrated
filters [36, 37]. In agreement with theory [31], we
found that both optical throughput and FWHM de-
crease substantially as the F/# of the objective lens is
increased. The coupling optics should therefore be
carefully considered when integrating SRDAs into
biomedical imaging systems. We found that an ob-
jective lens F/# of 1.65 offered a good compromise
between sensitivity (high) and adequate spectral res-
olution (low) for the low light levels and broad spec-
tra associated with the small molecule fluorescent
dyes used here.
Integrating the camera into a reflectance-based
widefield imaging system provided the first proof-of-
concept for fHSI using an SRDA. We exploited the
spectral component of the HSI data cube for back-
Figure 5 fHSI can detect four fluorescent dyes at depth in
tissue mimicking phantoms. (A) Photograph of the phan-
tom containing AlexaFluor dye inclusions before and after
the addition of a 2.5 mm thick slab of tissue mimicking
agarose gel. (B) Merged pseudocolor abundance maps for
each dye with and without OSP background removal in
pre-processing. The maximum intensity value in each fluo-
rescence abundance map is rescaled to a LS score of 1 for
visualization. (C) The LS score of the fluorescent in-
clusions as a function of depth. The red data markers in-
dicate the last data point with a weighted contrast-to-noise
ratio (CNR) of 4 or higher. Error bars indicate the meas-
urement uncertainty of the thickness of the agarose gel
slabs. (D) A comparison of the spectral unmixing pre-
cisions show that whilst it is possible to identify the dyes
based on a majority decision for the OSP pre-processed
data, this is not possible without background removal.
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ground removal using OSP. Our results demon-
strated simultaneous imaging and unmixing of up to
seven commonly used fluorescent dyes with highly
overlapping emissions in pure solutions. When pre-
pared in mixtures, fluorescent dyes naturally ‘bleed
over’ i. e. the emission of one excites another, which
affects any attempt to quantify concentration of
highly overlapping dyes (independent of the imaging
system used). We therefore focused on extracting
quantitative data of four relatively well spectrally
separated dyes. The presence of individual dyes at a
given location could be identified based on majority
decisions in our data: in superficial well plates; at
depths of several millimetres in tissue mimicking
phantoms; and in vivo in mice. We compared our in
vivo to images from a traditional filterbased fluores-
cence system, which reinforces the advantage of in-
creased spectral sampling for multiplexed fluores-
cence imaging.
Although our fHSI system shows promise, there
remain some limitations to this study. Firstly, the sys-
tem performance is limited by the low QE and dy-
namic range of the commercial CMOS image sensor
used in the HSI camera. Future integration of the
optical filters onto a scientific grade sensor could
overcome the QE limitations. Dynamic range could
Figure 6 fHSI enables spectral resolution of four AlexaFluor dyes in living subjects. (A) Abundance maps and the pseudo-
color images show clear resolution of separate injection sites (indicated by arrows) of each fluorescent dye for the fHSI.
(B) Abundance maps from a mixed injection of all four dyes. Intensity scale bar indicates LS score in both cases, with
spatial scale bar=5 mm. Data acquired using a filter based approach is shown for reference to the right. ROIs of 30 pixel
radii were then placed over the separate subcutaneous injection site on the fHSI and filter-based image data to extract
average LS scores (C) (background in red defined as all pixels outside of the injection site ROIs), spectral unmixing
precision (D) and from the filter-based data, maximum radiance (E).
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be extended using a sensor with spatially program-
mable exposure times or through application specif-
ic filter design to exclude reflected excitation light.
Secondly, while we were able to demonstrate quanti-
tative imaging in solutions in vitro, achieving this in
vivo is more challenging as sample topology and the
optical properties of tissue can modulate the re-
corded fluorescence spectra and this must be care-
fully accounted for, especially when imaging at
depth [17, 38]. Thirdly, in this work, all data process-
ing is performed offline but for many in vivo imag-
ing applications, the abundance maps would need to
be reconstructed in real time; transferring our data
processing algorithms onto graphical processing
units could achieve the required processing speeds.
Finally, while pushbroom imaging is acceptable for
static (or low temporal resolution) samples (e.g. for
optical inspection of excised tissues after surgery),
for video-rate applications such as endoscopic and
intra-operative imaging, a pixel level deposition of
filters is preferable, requiring a trade-off between
spectral and spatial resolution.
In summary, we have designed, characterized and
applied a novel SRDA-based HSI camera in a wide-
field reflectance-based fluorescence imaging system.
We demonstrated that our fHSI system shows prom-
ise for multiplexed fluorescence imaging in solutions
in vitro and in vivo in mice. These data are highly
encouraging, indicating that in addition to removing
reflected light, fHSI combined with OSP could in
the future enable diffuse reflectance and auto-
fluorescence to be separately resolved from fluo-
rescent dyes in clinical applications. Exploiting
SRDAs, fHSI using targeted molecular imaging flu-
orescent contrast agents could find application in
endoscopic cancer diagnosis and intra-operative tu-
mour resections, improving disease classification and
margin identification respectively.
Supporting information
Additional supporting information may be found in
the online version of this article at the publisher’s
website.
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